E. Cheung

Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.

L. Harker, L. Roskos, U. Marzec, 2000, Blood.

Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers

L. Harker, L. Roskos, U. Marzec, 2000 .

Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.

S. Hanson, L. Harker, U. Marzec, 1996, Blood.

The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice.

G. Senaldi, J. Guo, T. Ulich, 1999, Experimental hematology.

Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.

S. Hanson, L. Harker, U. Marzec, 1997, Blood.

Pharmacokinetic Analysis of Pegylated Megakaryocyte Growth and Development Factor in Humans

C. Begley, J. Cebon, L. Roskos, 2000, Growth factors.

Population Pharmacokinetic–Pharmacodynamic Modeling of Filgrastim (r-metHuG-CSF) in Healthy Volunteers

Bing Wang, Thomas M. Ludden, B. Wang, 2001, Journal of Pharmacokinetics and Pharmacodynamics.

Effective and efficient platelet transfusion strategies that maintain hemostatic protection

L. Harker, L. Roskos, E. Cheung, 1998, Transfusion.